Fig. 3: Kaplan-Meier survival analyses predicting.

a invasive Disease-Free Survival (iDFS), b distant Disease-Free Survival (dDFS), c Overall Survival (OS), d invasive Disease-Free Survival (iDFS) in TNBC, e distant Disease-Free Survival (dDFS) in TNBC and f Overall Survival (OS) in TNBC. Patients were dichotomized into those with ≤ 2GCs versus >2 GCs in all assessed cancer-free LNs. P values correspond to likelihood ratio tests.